Literature DB >> 3088202

aIr-1, a newly found locus on mouse chromosome 16 encoding a trans-acting activator factor for MHC class II gene expression.

R S Accolla, M Jotterand-Bellomo, L Scarpellino, A Maffei, G Carra, J Guardiola.   

Abstract

RJ 2.2.5 is a human B cell line that has lost the capacity to express MHC class II genes. The human class II-positive phenotype is restored in somatic cell hybrids between RJ 2.2.5 and mouse spleen cells. By karyotype and molecular studies of an informative family of hybrids we have now shown that the reexpression of human class II gene products, as well as the maintenance of the mouse class II-positive phenotype, correlates with the presence of mouse chromosome 16. Thus, the existence on this mouse chromosome of a newly found locus, designated by us aIr-1, that determines a trans-acting activator function for class II gene expression, is established. Possible implications of this finding are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3088202      PMCID: PMC2188193          DOI: 10.1084/jem.164.1.369

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  Sequences of mouse immunoglobulin light chain genes before and after somatic changes.

Authors:  O Bernard; N Hozumi; S Tonegawa
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

2.  Non-random chromosome gains in human lymphoblastoid cell lines.

Authors:  C M Steel; M A Woodward; C Davidson; J Philipson; E Arthur
Journal:  Nature       Date:  1977-11-24       Impact factor: 49.962

3.  Reactivation by a trans-acting factor of human major histocompatibility complex Ia gene expression in interspecies hybrids between an Ia-negative human B-cell variant and an Ia-positive mouse B-cell lymphoma.

Authors:  R S Accolla; G Carra; J Guardiola
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

4.  Epitopic analysis of detergent-solubilized HLA molecules by solid-phase radioimmunoassay.

Authors:  F A Lemonnier; N Rebai; P P Le Bouteiller; B Malissen; D H Caillol; F M Kourilsky
Journal:  J Immunol Methods       Date:  1982-10-15       Impact factor: 2.303

5.  Ia-negative B-cell variants reveal a coordinate regulation in the transcription of the HLA class II gene family.

Authors:  E O Long; B Mach; R S Accolla
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

6.  Paired H-2-specific monoclonal antibodies react differently to red cells and lymphocytes.

Authors:  S L Tonkonogy; D B Amos
Journal:  Immunogenetics       Date:  1981-12       Impact factor: 2.846

7.  Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression.

Authors:  K Ozato; D H Sachs
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

8.  Trans-acting element(s) operating across species barriers positively regulate expression of major histocompatibility complex class II genes.

Authors:  R S Accolla; L Scarpellino; G Carra; J Guardiola
Journal:  J Exp Med       Date:  1985-10-01       Impact factor: 14.307

9.  Analysis of the structural heterogeneity and polymorphism of human Ia antigens. Four distinct subsets of molecules are coexpressed in the Ia pool of both DR1,1 homozygous and DR3,W6 heterozygous B cell lines.

Authors:  R S Accolla
Journal:  J Exp Med       Date:  1984-02-01       Impact factor: 14.307

10.  Chromosomal location of structural genes encoding murine immunoglobulin lambda light chains. Genetics of murine lambda light chains.

Authors:  P D'Eustachio; A L Bothwell; T K Takaro; D Baltimore; F H Ruddle
Journal:  J Exp Med       Date:  1981-04-01       Impact factor: 14.307

View more
  45 in total

1.  Two distinct domains within CIITA mediate self-association: involvement of the GTP-binding and leucine-rich repeat domains.

Authors:  M W Linhoff; J A Harton; D E Cressman; B K Martin; J P Ting
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

Review 2.  Class II transactivator: mastering the art of major histocompatibility complex expression.

Authors:  J A Harton; J P Ting
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  Contrasting effects of IFNα on MHC class II expression in professional vs. nonprofessional APCs: Role of CIITA type IV promoter.

Authors:  Laura Pisapia; Giovanna Del Pozzo; Pasquale Barba; Alessandra Citro; Paul E Harris; Antonella Maffei
Journal:  Results Immunol       Date:  2012-09-27

Review 4.  A family of trans-acting factors with distinct regulatory functions control expression of MHC class II genes.

Authors:  R S Accolla; P Dellabona; L Scarpellino; G Carra; S Sartoris
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

5.  Effect of the AIR-1 locus on the activation of an enhancerless HLA-DQA1 promoter.

Authors:  M N Ombra; G Del Pozzo; C Perfetto; A Maffei; J Guardiola
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

6.  Major histocompatibility complex class II transactivator CIITA is a viral restriction factor that targets human T-cell lymphotropic virus type 1 Tax-1 function and inhibits viral replication.

Authors:  Giovanna Tosi; Greta Forlani; Vibeke Andresen; Marco Turci; Umberto Bertazzoni; Genoveffa Franchini; Guido Poli; Roberto S Accolla
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

Review 7.  Genetics of HLA class II regulation.

Authors:  C R Hume; J S Lee
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

Review 8.  Adequate antigen availability: a key issue for novel approaches to tumor vaccination and tumor immunotherapy.

Authors:  Roberto S Accolla; Giovanna Tosi
Journal:  J Neuroimmune Pharmacol       Date:  2012-12-07       Impact factor: 4.147

9.  Methylation of CIITA promoter IV causes loss of HLA-II inducibility by IFN-gamma in promyelocytic cells.

Authors:  Andrea De Lerma Barbaro; Alessandro De Ambrosis; Barbara Banelli; Giuseppina Li Pira; Ottavia Aresu; Massimo Romani; Silvano Ferrini; Roberto S Accolla
Journal:  Int Immunol       Date:  2008-10-01       Impact factor: 4.823

10.  Physiologic target of the Air-1 trans-activator revealed by stable transfection assay.

Authors:  S Sartoris; A De Lerma Barbaro; T Cestari; G Tridente; R S Accolla
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.